Correction to: Scientific Reports https://doi.org/10.1038/s41598-018-20255-x, published online 30 January 2018
In this Article, Figure 4O is a duplication of Figure 3B. The correct Figure 4 appears below as Figure 1.
In vitro therapeutic efficacy assessment on (A) SKOV-3 and (B) HeLa cells by PTX-CPP modified Mn:ZnS NPs after 48 h incubation; The control vehicle concentration is 50, 100, and 200 μg/mL, whereas the control PTX concentration is 10, 20 and 30 μM. The actual PTX concentration in samples are 0.2, 0.4 and 0.8 μM respectively. (n = 6, **represents p < 0.01, ***represents p < 0.001); (C–N) represents the apoptotic profile on SKOV-3 and HeLa cells by the developed PTX formulations with CPP modified Mn:ZnS NPs: (C) Control SKOV-3 cells; (D) Mn:ZnS NPs; (E) PEN/Mn:ZnS NPs; (F) pVEC/Mn:ZnS NPs; (G) R9/Mn:ZnS NPs and (H) Control PTX; (I) control HeLa; (J) Mn:ZnS NPs; (K) PEN/Mn:ZnS NPs; (L) pVEC/Mn:ZnS NPs; (M) R9/Mn: ZnS NPs and (N) Control PTX cells after 48 h incubation time. (O–Z) Shows the confocal laser scanning electron microscopic images on SKOV3 and HeLa cells: (O) control SKOV-3; (U) Control HeLa cells; (P,V) PTX:Mn:ZnS NPs; (Q,W) PTX:PEN/Mn:ZnS NPs; (R,X) PTX/pVEC:Mn:ZnS NPs; (S,Y) PTX:R9/Mn:ZnS NPs and (T,Z) Control PTX respectively after 48 h incubation time. Blue fluorescence is DAPI staining on the nucleus and red fluorescence indicates the Mn:ZnS NPs (scale bar = 50 μm).
In addition, Figure 6B is a duplication of Figure 6D. The correct Figure 6 appears below as Figure 2.
Bio-distribution analysis of IR-780 doped samples on 4T1 tumor model. Left to right samples: Control mice, control dye, IR-780:Mn:ZnS NPs, IR-780:PEN/Mn:ZnS NPs, IR-780:pVEC/Mn:ZnS NPs, IR-780:R9/Mn:ZnS NPs respectively from 1 hour to 168 h. (B–G) shows tumor vs organ ex vivo bio-imaging on 4T1 tumor model one week after i.v injection. (B) Control mice; (C) control dye; (D) IR-780:Mn:ZnS NPs; (E) IR-780:PEN/Mn:ZnS NPs, (F) IR-780:pVEC/Mn:ZnS NPs, (G) IR-780:R9/Mn:ZnS NPs respectively.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Rejinold, N.S., Han, Y., Yoo, J. et al. Author Correction: Evaluation of cell penetrating peptide coated Mn:ZnS nanoparticles for paclitaxel delivery to cancer cells. Sci Rep 8, 13488 (2018). https://doi.org/10.1038/s41598-018-31646-5
Published:
DOI: https://doi.org/10.1038/s41598-018-31646-5
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
